BSE filing, NSE: BODHTREE. Summary written from the filing by ALFA Finder's alert engine.
Datakosa Ltd: key numbers
- Share price
- ₹15.90
- Market cap
- ₹34.77 Cr
- Revenue (annual)
- ₹19.43 Cr
- Net profit (annual)
- ₹1.43 Cr
- P/E (TTM)
- -82.0×Sector 23.7×
- Promoter holding
- 73.17%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Datakosa Ltd
All →Datakosa Preferential Issue
Datakosa received BSE listing approval for 20,58,822 equity shares issued on a preferential basis to non-promoters at ₹17 per share. The approval is a post-allotment listing step in a preferential issue.
- Value
- ₹3.50 Cr
Datakosa Bags ₹23.38 Cr Order from Hermes Networks Inc., USA
Datakosa received a work order from Hermes Networks Inc., USA, for AI automation services worth USD 24,65,280 (about INR 23.38 Crore). Execution runs 12 months from 1 November 2026.
- Value
- ₹23.38 Cr
- From
- Hermes Networks Inc., USA
- Execution
- 12 months, from 1 November 2026 to 31 October 2027
Datakosa Annual Report
Bodhtree Consulting filed its 44th Annual Report for FY 2025-26 with the AGM notice for September 9, 2026. It reports no new transaction or financial event.
Datakosa Q2 FY27 Results: Net Profit ₹0.4 Cr, Up 0.0% YoY
Datakosa Ltd reported revenue from operations of ₹2.2 Cr (-38.9% YoY) and net profit of ₹0.4 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.4 Cr · +0.0% YoY
Datakosa Board Meeting Date
Datakosa Limited has scheduled a board meeting for October 23, 2026, to consider and approve the company's unaudited financial results for the quarter ending September 30, 2026.
Bodhtree Consulting Other Announcement
Bodhtree Consulting Limited has received approval from BSE to change its corporate name to Datakosa Limited, effective from October 15, 2026.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr